Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study

Hum Gene Ther. 1994 Aug;5(8):1059-64. doi: 10.1089/hum.1994.5.8-1059.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II

MeSH terms

  • Animals
  • Clinical Protocols*
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Humans
  • Interleukin-4 / administration & dosage
  • Interleukin-4 / genetics
  • Interleukin-4 / immunology
  • Interleukin-4 / therapeutic use*
  • Melanoma / immunology
  • Melanoma / therapy*
  • Mice
  • Tumor Cells, Cultured / immunology
  • Tumor Cells, Cultured / transplantation
  • Vaccination

Substances

  • Interleukin-4